This article is more than 5 years old. Information may no longer be current.

Hospital for Special Surgery receives $10 million grant from Stavros Niarchos Foundation

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Hospital for Special Surgery announced it received a $10 million grant from the Stavros Niarchos Foundation for the operation and expansion of the Complex Joint Reconstruction Center’s clinical, research and educational programs.

Thomas P. Sculco

“This generous gift will improve the lives of countless patients who suffer from debilitating complications or need revision surgery due to failed implants,” Thomas P. Sculco, MD, surgeon-in-chief emeritus and director of the Complex Joint Reconstruction Center at Hospital for Special Surgery (HSS), said in a press release. “We are deeply honored by the visionary leadership of the SNF in supporting our endeavor to lessen implant failure, restore function and relieve pain for patients who need specialized joint reconstructions.”

According to the release, the Stavros Niarchos Foundation (SNF) Complex Joint Reconstruction Center provides diagnosis and treatment for patients with challenging conditions in joint reconstruction, regardless of financial circumstances. The center also conducts cutting-edge basic and clinical research on the causes and prevention of implant failure. The release noted the center launched a patient registry dedicated to capturing clinical and outcomes data from patients undergoing joint reconstruction and complex primary joint replacement surgery, creating a platform for clinical trials, translational research and innovations in treatment that will lead to improved standards of care.

“Having partnered with HSS for over a decade, the SNF has witnessed first-hand the deep commitment of the people of HSS to excellence and progress in orthopedic care,” Andreas Dracopoulos, co-president of the SNF, said in the release. “We are especially proud to support Dr. Sculco’s vision to improve the lives of patients with the most complex cases of joint reconstruction, and to seek solutions to issues that impact the field at large.”

Reference: